V CON 90 by Chemisis Pharmaceuticals contains Etoricoxib, a selective COX-2 inhibitor (coxib) that provides potent anti-inflammatory and analgesic effects. Etoricoxib is commonly used to treat a variety of conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain, including gouty arthritis and postoperative pain.

• Etoricoxib 90 mg: This active ingredient selectively inhibits the cyclooxygenase-2 (COX-2) enzyme, which is involved in the inflammation process. By targeting COX-2, Etoricoxib reduces pain and inflammation while minimizing gastrointestinal side effects that are more common with non-selective NSAIDs.

The typical dosage of V CON 90 is one 90 mg tablet taken once daily, with or without food. It is important to follow the healthcare provider’s instructions regarding the dosage and duration of treatment to achieve optimal results. Common side effects of Etoricoxib may include headache, dizziness, stomach pain, nausea, and diarrhea. Serious side effects are rare but can include cardiovascular events such as heart attack and stroke, gastrointestinal bleeding, and severe allergic reactions. Patients should be aware of these risks and report any unusual symptoms to their healthcare provider immediately. It is particularly important for patients with a history of cardiovascular disease, high blood pressure, or gastrointestinal issues to consult their healthcare provider before starting this medication.